These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3769556)
1. Dermatitis herpetiformis and vitiligo. Hogan DJ; Lane PR Cutis; 1986 Sep; 38(3):195-7. PubMed ID: 3769556 [TBL] [Abstract][Full Text] [Related]
2. Dermatitis herpetiformis and vitiligo: report of a case and review of the literature. Amato L; Gallerani I; Fuligni A; Mei S; Fabbri P J Dermatol; 2000 Jul; 27(7):462-6. PubMed ID: 10935345 [TBL] [Abstract][Full Text] [Related]
3. Dermatitis herpetiformis and vitiligo. Karabudak O; Dogan B; Yildirim S; Harmanyeri Y; Anadolu-Brasie R J Chin Med Assoc; 2007 Nov; 70(11):504-6. PubMed ID: 18063505 [TBL] [Abstract][Full Text] [Related]
4. Dermatitis herpetiformis and bullous pemphigoid: a developing association confirmed by immunoelectronmicroscopy. Setterfield J; Bhogal B; Black MM; McGibbon DH Br J Dermatol; 1997 Feb; 136(2):253-6. PubMed ID: 9068744 [TBL] [Abstract][Full Text] [Related]
6. Dermatitis herpetiformis and vitiligo. Hazelrigg DE Cutis; 1987 Mar; 39(3):232. PubMed ID: 3829730 [No Abstract] [Full Text] [Related]
7. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. Hall RP; Clark RE; Ward FE J Am Acad Dermatol; 1990 Mar; 22(3):436-9. PubMed ID: 2312829 [TBL] [Abstract][Full Text] [Related]
11. Dermatitis herpetiformis and vitiligo. Olholm-Larsen P; Kavli G Dermatologica; 1980; 160(1):41-4. PubMed ID: 7351269 [TBL] [Abstract][Full Text] [Related]
12. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Kárpáti S; Kósnai I; Verkasalo M; Kuitunen P; Simon Z; Koskimies S; Reunala T; Gyódi E; Török E Acta Paediatr Scand; 1986 Mar; 75(2):297-301. PubMed ID: 3962661 [TBL] [Abstract][Full Text] [Related]
13. Dermatitis herpetiformis and primary sclerosing cholangitis. Lewis HM; Goldin R; Leonard JN Clin Exp Dermatol; 1993 Jul; 18(4):363-5. PubMed ID: 8403478 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Gaspari AA; Huang CM; Davey RJ; Bondy C; Lawley TJ; Katz SI Am J Med; 1990 Feb; 88(2):145-50. PubMed ID: 2301441 [TBL] [Abstract][Full Text] [Related]
15. Dermatitis herpetiformis and leiomyomas with HLA-B8, a marker of immune diseases. Grenier R; Rostas A; Wilkinson RD Can Med Assoc J; 1976 Nov; 115(9):882-4. PubMed ID: 991036 [TBL] [Abstract][Full Text] [Related]
17. Dermatitis herpetiformis arising within vitiligo in a patient with autoimmune polyendocrine syndrome type 3. Köykkä H; Lappalainen K; Kluger N Int J Dermatol; 2019 Jun; 58(6):e123-e125. PubMed ID: 30924131 [No Abstract] [Full Text] [Related]
18. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. Lawley TJ; Hall RP; Fauci AS; Katz SI; Hamburger MI; Frank MM N Engl J Med; 1981 Jan; 304(4):185-92. PubMed ID: 6969363 [TBL] [Abstract][Full Text] [Related]
19. [Dermatitis herpetiformis Duhring with linear deposits of IgA (linear IgA dermatosis)]. Meurer M; Schmoeckel C; Braun-Falco O Hautarzt; 1984 May; 35(5):230-9. PubMed ID: 6378830 [TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine-induced generalized vitiligo in a patient with dermatitis herpetiformis and celiac disease. Turkowski Y; Konnikov N Dermatol Ther; 2019 Sep; 32(5):e13007. PubMed ID: 31237078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]